Eli Lilly brings much-awaited weight-loss drug Mounjaro to India
The much-awaited launch of Mounjaro, an injectable drug used to treat obesity, overweight, and type 2 diabetes, has been ...
Where Will Eli Lilly Be in 5 Years?
It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares leaving ...
Fierce Pharma1d
Lilly backs study in mission to improve Hollywood representations of obesity, diabetes, dementia and more
Hollywood has in recent years been undergoing a much-needed, long-awaited transformation in its portrayals of women and ...
Blockbuster weight-loss drug Mounjaro comes to India: How does it work?
The popular anti-obesity drug Mounjaro has finally been launched in India. The development comes after Eli Lilly received ...
Yahoo Finance19d
Where Will Eli Lilly Be in 5 Years?
Of course, Lilly's most important new products are diabetes treatment ... surprised if its annual top-line growth goes lower than 15% in any year through 2030. Eli Lilly has several exciting ...
3 Magnificent Growth Stocks to Buy in March
What's considered excellent revenue growth depends on the industry. With that context in mind, consider that Eli Lilly's ...
Mounjaro can boost weight loss in people without diabetes
People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...
Billionaire Ken Griffin More Than Doubled His Stake In This Market-Beating Growth Stock
"Billionaire" and "successful hedge fund manager" are titles that carry significant weight on Wall Street. These and others ...
Eli Lilly and Company (LLY): Jim Cramer Says ‘Don’t Sell’ – A Visionary Stock to Hold!
On Thursday, Jim Cramer, the host of Mad Money, discussed the recent turbulence in the stock market, pointing to the lack of ...